Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by St. Claraspital AG.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
St. Claraspital AG
ClinicalTrials.gov Identifier:
NCT00835055
First received: February 2, 2009
Last updated: September 21, 2009
Last verified: September 2009
  Purpose

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.


Condition
Rectal Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by St. Claraspital AG:

Estimated Enrollment: 100
Study Start Date: April 2005
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

group is selected from a single institution ( community hospital)

Criteria

Inclusion Criteria:

  • locally advanced rectal cancer uT3 or uT4
  • no distant metastasis
  • neoadjuvant radiochemotherapy required

Exclusion Criteria:

  • rejection of radiochemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00835055

Contacts
Contact: Beatrice Kern, MD +41 61 685858585 ext 8484 beatrice.kern@claraspital.ch

Locations
Switzerland
St. Claraspital, Chirurgische Klinik Recruiting
Basel, Switzerland, 4016
Contact: Beatrice Kern, MD    +41 61 6858585 ext 8484    beatrice.kern@claraspital.ch   
Sponsors and Collaborators
St. Claraspital AG
  More Information

No publications provided

Responsible Party: Dr. Urs Wagner, Viollier AG
ClinicalTrials.gov Identifier: NCT00835055     History of Changes
Other Study ID Numbers: 43/05
Study First Received: February 2, 2009
Last Updated: September 21, 2009
Health Authority: Switzerland: Ethikkommission

Keywords provided by St. Claraspital AG:
rectal cancer with neoadjuvant treatment
standardized clinical tests
tumor markers on tumor tissue

Additional relevant MeSH terms:
Rectal Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on August 21, 2014